Balazs Radnai

7PUBLICATIONS
31CO-AUTHORS
Medical mycologyNanomaterialsHealth and ecological risk assessmentCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 27, 2026
Selective MIF Enolase Inhibitor TE-91 Regulates M1 Polarization and Associated Metabolic Reprogramming.

|Aug 27, 2025
Gold Nanoparticles Disrupt Mitochondrial Activity in Hypothalamic POMC Cells: Implications for Energy Homeostasis.

Boglárka Mária Schilling-Tóth, Silvia Ondrašovičová, Eszter Vámos

|Oct 28, 2023
Highly Selective MIF Ketonase Inhibitor KRP-6 Diminishes M1 Macrophage Polarization and Metabolic Reprogramming.

Eszter Vámos, Nikoletta Kálmán, Eva Maria Sturm

|Aug 26, 2022
Distinct Uptake Routes Participate in Silver Nanoparticle Engulfment by Earthworm and Human Immune Cells.

Bohdana Kokhanyuk, Viola Bagóné Vántus, Balázs Radnai

|Sep 27, 2021
Olaparib: A Clinically Applied PARP Inhibitor Protects from Experimental Crohn's Disease and Maintains Barrier Integrity by Improving Bioenergetics through Rescuing Glycolysis in Colonic Epithelial Cells.

Dominika Kovács, Viola Bagóné Vántus, Eszter Vámos

|Jul 06, 2021
Tetralone derivatives are MIF tautomerase inhibitors and attenuate macrophage activation and amplify the hypothermic response in endotoxemic mice.

János Garai, Marcell Krekó, László Őrfi

Pageof 2

Frequent Collaborators

6 joint publications

Eszter Vámos

4 joint publications

Dominika Kovacs

4 joint publications

Ferenc Gallyas

3 joint publications

Nikoletta Kalman